Annual ROE
-297.68%
-264.07%-785.69%
December 31, 2023
Summary
- As of February 6, 2025, CADL annual return on equity is -297.68%, with the most recent change of -264.07% (-785.69%) on December 31, 2023.
- During the last 3 years, CADL annual ROE has fallen by -372.72% (-496.70%).
- CADL annual ROE is now -390.39% below its all-time high of 102.51%, reached on December 31, 2019.
Performance
CADL ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
3209.78%
+3839.07%+610.06%
September 30, 2024
Summary
- As of February 6, 2025, CADL quarterly return on equity is 3209.78%, with the most recent change of +3839.07% (+610.06%) on September 30, 2024.
- Over the past year, CADL quarterly ROE has increased by +3839.07% (+610.06%).
- CADL quarterly ROE is now at all-time high.
Performance
CADL Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CADL ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -785.7% | +610.1% |
| 3 y3 years | -496.7% | +9930.9% |
| 5 y5 years | -390.4% | +9930.9% |
CADL ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -785.7% | at low | at high | +610.1% |
| 5 y | 5-year | -390.4% | at low | at high | +610.1% |
| alltime | all time | -390.4% | at low | at high | +610.1% |
Candel Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 3209.78%(-610.1%) |
| Jun 2024 | - | -629.29%(+205.3%) |
| Mar 2024 | - | -206.10%(+44.2%) |
| Dec 2023 | -297.68%(+785.7%) | -142.91%(+58.0%) |
| Sep 2023 | - | -90.47%(+19.7%) |
| Jun 2023 | - | -75.60%(+41.2%) |
| Mar 2023 | - | -53.55%(+64.0%) |
| Dec 2022 | -33.61% | -32.65%(+63.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -19.99%(-57.6%) |
| Jun 2022 | - | -47.14%(-65.1%) |
| Mar 2022 | - | -135.26%(-75.4%) |
| Dec 2021 | -178.06%(-337.3%) | -549.16%(-189.0%) |
| Sep 2021 | - | 616.99%(+460.3%) |
| Jun 2021 | - | 110.12%(+37.9%) |
| Mar 2021 | - | 79.85%(+6.4%) |
| Dec 2020 | 75.04%(-26.8%) | 75.04% |
| Dec 2019 | 102.51% | - |
FAQ
- What is Candel Therapeutics annual return on equity?
- What is the all time high annual ROE for Candel Therapeutics?
- What is Candel Therapeutics annual ROE year-on-year change?
- What is Candel Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Candel Therapeutics?
- What is Candel Therapeutics quarterly ROE year-on-year change?
What is Candel Therapeutics annual return on equity?
The current annual ROE of CADL is -297.68%
What is the all time high annual ROE for Candel Therapeutics?
Candel Therapeutics all-time high annual return on equity is 102.51%
What is Candel Therapeutics annual ROE year-on-year change?
Over the past year, CADL annual return on equity has changed by -264.07% (-785.69%)
What is Candel Therapeutics quarterly return on equity?
The current quarterly ROE of CADL is 3209.78%
What is the all time high quarterly ROE for Candel Therapeutics?
Candel Therapeutics all-time high quarterly return on equity is 3209.78%
What is Candel Therapeutics quarterly ROE year-on-year change?
Over the past year, CADL quarterly return on equity has changed by +3839.07% (+610.06%)